Health care and pharmacy supply chain has become one of the most important industries in India and is increasingly being targeted by the government for reform.
In a move that may cause more problems for the supply chain, the government has ordered the national pharmacy chain to supply its cobra brand supplement to all hospitals in the country, a move to limit the supply of a product that is a vital part of a long-term, national health strategy.
According to a government notification, the national pharmacists are required to submit a report by February 15 detailing all medicines purchased by their patients between January 1 and March 31, 2019.
The report will be sent to the government in two formats.
The first format includes the name of the pharmacy, the name and address of the pharmacist and the date of the purchase.
The second format will include the name, address and date of sale of the medication.
The government is also planning to introduce a special dispensing policy for the cobra supplement, in line with the Indian pharmacist policy, which has already been implemented in several other countries, including Germany, France and Italy.
According the government, this will ensure that a timely supply of the cobrains supplement can be available at all hospitals, as well as ensuring that the supplement can provide long-lasting relief.
The ministry of health and family welfare, the health ministry and the government health and drug policy department have been working to implement the policy.
In its notification, Health Minister Anand Kumar Bajaj had said, “There is a need for quick supply of cobrases supplement to the country.
This will provide relief to patients in the long run.
We want to make sure that all health centres are prepared for the sudden influx of the product.”
The government is considering an option of issuing a notification to the pharmacies to supply the product to the hospitals within the next two weeks.
The supply of an essential product like cobraces supplement is highly critical to the health and well-being of the population in India, as it can help the country’s chronic disease control.
According to data released by the Indian Council of Medical Research, the average life expectancy of a person is currently around 86 years, with the average number of years of life lost per 100,000 deaths being 3.6.
According, the cobras supplement is a brand of vitamin C, which is considered a crucial component in the body’s defence against infection.
It has also been recommended by the World Health Organization as a preventive medicine for over 20 years.
The government has been seeking a solution to the supply crisis for over a year now.
The health ministry has taken up the issue with the pharmaceutical industry, and is working with pharmaceutical companies in an attempt to bring the supplement to markets in the next couple of weeks.